Virtu Financial’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,162
| Closed | -$13K | – | 2236 |
|
|
2024
Q4 | $13K | Buy |
+31,162
| New | +$26K | ﹤0.01% | 1363 |
|
|
2024
Q2 | – | Sell |
-13,096
| Closed | -$39K | – | 2077 |
|
|
2024
Q1 | $39K | Buy |
13,096
+3,018
| +30% | +$14.1K | ﹤0.01% | 1063 |
|
|
2023
Q4 | $63K | Buy |
+10,078
| New | +$77K | 0.01% | 1137 |
|
|
2022
Q3 | – | Sell |
-65
| Closed | -$52K | – | 2372 |
|
|
2022
Q2 | $52K | Buy |
65
+62
| +2,067% | +$91.9K | ﹤0.01% | 1121 |
|
|
2022
Q1 | $9K | Sell |
3
-51
| -94% | -$108K | ﹤0.01% | 1373 |
|
|
2021
Q4 | $140K | Buy |
54
+39
| +260% | +$136K | 0.01% | 977 |
|
|
2021
Q3 | $68K | Buy |
15
+5
| +50% | +$25.2K | 0.01% | 1222 |
|
|
2021
Q2 | $57K | Sell |
10
-9
| -47% | -$58.1K | 0.01% | 1316 |
|
|
2021
Q1 | $153K | Hold |
19
| – | – | 0.01% | 1186 |
|
|
2020
Q4 | $117K | Buy |
+19
| New | +$116K | 0.01% | 1017 |
|
|
2019
Q4 | $105K | Buy |
18
+12
| +200% | +$113K | 0.01% | 1075 |
|
|
2019
Q3 | $79K | Sell |
6
-7
| -54% | -$56.2K | 0.01% | 1129 |
|
|
2019
Q2 | $106K | Buy |
13
+9
| +225% | +$105K | 0.01% | 1127 |
|
|
2019
Q1 | $48K | Sell |
4
-3
| -43% | -$51K | ﹤0.01% | 1214 |
|
|
2018
Q4 | $107K | Buy |
+7
| New | +$164K | 0.01% | 1115 |
|
|
2018
Q2 | – | Sell |
-5
| Closed | -$175K | – | 2615 |
|
|
2018
Q1 | $175K | Buy |
+5
| New | +$135K | 0.01% | 1412 |
|
Virtu Financial's TTOO Position: Q1 2025 in Review
Virtu Financial sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 31,162 shares — an estimated $13K sold.
Virtu Financial first reported a position in TTOO in Q1 2018 and held it in 16 quarters. The position peaked at $175K in Q1 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Virtu Financial reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Virtu Financial sold 31,162 T2 Biosystems, Inc shares in Q1 2025, an estimated $13K.
- Virtu Financial first reported a position in T2 Biosystems, Inc in Q1 2018 and held it in 16 quarters.
- Virtu Financial's T2 Biosystems, Inc position peaked at $175K in Q1 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.